Learn About The Latest HER2 Testing In Breast Cancer Guidelines Recommendations: Practical Approaches For Applying Them To Your Practice
Find answers to your questions about the interpretation criteria, diagnostic categories, and rationale for changes in the Updated HER2 Testing in Breast Cancer Guideline, jointly published by the American Society of Clinical Oncology (ASCO) and the CAP. This session will focus on what has changed and how these changes might affect HER2 test workup, interpretation and reporting in your laboratory. The CAP is committed to keeping these guidelines as living documents that continually adapt to new evidence to improve patient outcomes, whether it is through improved accuracy in laboratory testing or improved communication among health care providers and patients.
- Illustrate how to identify candidates for HER2 targeted therapy accurately through challenging case studies presented with their optimal solutions
- Share the latest HER2 testing expertise and practical approaches on applying the updates to your practice.
Handout (PDF, 9.04 MB)
Kimberly H. Allison, MD